Skip to content

Illumina ILMN EPS (Diluted)

EPS (Diluted) at other companies

Revvity logo
RevvityRVTY
$0.36+2.9%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.43+11.3%
Azenta logo
AzentaAZTA
-$3.49-236%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$0.29-61.1%
Guardant Health logo
Guardant HealthGH
-$0.85-10.4%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
-$0.71-7.6%

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
Operating cash flow$289.0M+20.4%
CapEx$38.0M+18.8%
Free cash flow$251.0M+20.7%

Valuation

See full
Market cap$26.6B+91.5%
Enterprise value$27.56B+83.6%
P/E31.2×+20.1×
P/S6.1×+2.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%
Net margin19.4%+12.7pp
FCF margin22.2%+2.0pp

Returns & leverage

See full
Return on equity33.8%+23.9pp
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's EPS (diluted)?
Illumina (ILMN) reported EPS (diluted) of $0.87 in Q1 2026.
How has Illumina's EPS (diluted) changed year-over-year?
Illumina's EPS (diluted) increased by 6.1% year-over-year, from $0.82 to $0.87.
What is the long-term trend for Illumina's EPS (diluted)?
Over 3 years (2021 to 2025), Illumina's EPS (diluted) has grown at a 2.8% compound annual growth rate (CAGR), from $5.02 to $5.45.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.